Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation

20 Jul 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to Microtubule and mitosis dynamics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30033091
DOI: 10.1016/j.ccell.2018.06.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK ActivationPMID 30033091Read ↗

ROS1-dependent cancers — biology, diagnostics and therapeuticsSemantic proximity Read ↗

The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy.Semantic proximity Read ↗

Super-enhancer-driven HAVCR1 defines cisplatin resistance yet immunotherapy responsiveness in non-small-cell lung cancerSemantic proximity Read ↗

CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cellsSemantic proximity Read ↗

Cisplatin resistance: Preclinical findings and clinical implicationsSemantic proximity Read ↗

NAMPT: A critical driver and therapeutic target for cancerSemantic proximity Read ↗

MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptationSemantic proximity Read ↗

The effects of PEDF on cancer biology: mechanisms of action and therapeutic potentialSemantic proximity Read ↗

Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapySemantic proximity Read ↗

TUFT1 Facilitates Metastasis, Stemness, and Vincristine Resistance in Colorectal Cancer via Activation of PI3K/AKT PathwaySemantic proximity Read ↗

Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survivalSemantic proximity Read ↗

Combating pancreatic cancer chemoresistance by triggering multiple cell death pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.